RESEARCH TRIANGLE PARK, N.C., May 30, 2012-- Stiefel, a GSK GSK +0.11% company, and Welichem Biotech, Inc. (wbi:CN), have entered into an agreement for the acquisition by Stiefel of exclusive ...
LONDON--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE: GSK) and Sierra Oncology, Inc (Nasdaq: SRRA) today announced that the companies have entered into an agreement under which GSK will acquire ...
* GSK SEES SALES GROWTH MORE THAN 5% AND ADJUSTED OPERATING PROFIT GROWTH MORE THAN 10% CAGR 2021-26 * GSK - NEW CONSUMER HEALTHCARE COMPANY SHARES EXPECTED TO ATTAIN A PREMIUM LISTING ON THE LSE, ...
GSK Earnings: Strong Start to the Year Driven by Growth in Specialty Medicines GSK posted 6% year-on-year earnings growth at constant currency and core operating profit margin of 32.9%, or 180 basis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback